NCT05168605 Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
| NCT ID | NCT05168605 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Texas Southwestern Medical Center |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-07-27 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2022-07-27 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of study is to evaluate whether home visit programs are an effective method for HTN and T2DM management as compared to standard of care clinic visits.
Eligibility Criteria
Inclusion Criteria: * Adult patients ages 18-60 * Spanish or English speaking * Diagnosis of HTN or BP \>140/90 in last 3 months (based on medical record) * Hemoglobin A1C\>8 in last 6 months (based on medical record) * Not pregnant Exclusion Criteria: * Current oral steroid use * History of solid organ transplant * Language other than English or Spanish
Contact & Investigator
Nora Gimpel, M.D.
PRINCIPAL INVESTIGATOR
University of Texas Southwestern Medical Center
Frequently Asked Questions
Who can join the NCT05168605 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05168605 currently recruiting?
Yes, NCT05168605 is actively recruiting participants. Contact the research team at silvia.obregon@utsouthwestern.edu for enrollment information.
Where is the NCT05168605 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT05168605 clinical trial?
NCT05168605 is sponsored by University of Texas Southwestern Medical Center. The principal investigator is Nora Gimpel, M.D. at University of Texas Southwestern Medical Center. The trial plans to enroll 100 participants.